Shandong Bailong Chuangyuan Bio-Tech (605016.SS) Earnings Analysis

Shandong Bailong Chuangyuan Bio-Tech (605016.SS) has no confirmed upcoming earnings date. Trailing P/E 21.94.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 605016.SS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 605016.SS. This page updates as the calendar is published.

605016.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-300.29 CNYn/an/an/a
2026-04-080.25 CNYn/an/an/a
2025-10-130.2258 CNYn/an/an/a
2025-07-140.2713 CNYn/an/an/a
2025-04-300.25 CNYn/an/an/a
2025-02-170.1942 CNYn/an/an/a
2024-10-300.1951 CNYn/an/an/a

605016.SS valuation and analyst view

Trailing P/E21.94
Trailing EPS0.97072 CNY
Price / book4.60
Dividend yield1.16%
Market cap9.78B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Shandong Bailong Chuangyuan Bio-Tech (605016.SS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 605016.SS. This page updates as the calendar is published.

Did 605016.SS beat earnings last quarter?

Consensus estimate data was not available for 605016.SS's 2026-04-30 report.

What is 605016.SS's current P/E ratio and EPS?

605016.SS trades at a trailing P/E of 21.94 on trailing EPS of 0.9707249087360104 CNY.

What do analysts rate 605016.SS?

605016.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.